Zoetis, Inc. (ZTS)
85.57
+2.09
(+2.50%)
USD |
NYSE |
Nov 18, 16:00
84.92
-0.65
(-0.76%)
Pre-Market: 08:45
Zoetis Total Assets (Quarterly) : 15.09B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 15.09B |
| June 30, 2026 | 15.08B |
| March 31, 2026 | 15.15B |
| December 31, 2025 | 15.47B |
| September 30, 2025 | 15.16B |
| June 30, 2025 | 14.48B |
| March 31, 2025 | 14.10B |
| December 31, 2024 | 14.24B |
| September 30, 2024 | 14.36B |
| June 30, 2024 | 14.16B |
| March 31, 2024 | 14.35B |
| December 31, 2023 | 14.29B |
| September 30, 2023 | 14.11B |
| June 30, 2023 | 13.75B |
| March 31, 2023 | 13.75B |
| December 31, 2022 | 14.92B |
| September 30, 2022 | 13.67B |
| June 30, 2022 | 13.77B |
| March 31, 2022 | 13.86B |
| December 31, 2021 | 13.90B |
| September 30, 2021 | 13.70B |
| June 30, 2021 | 14.07B |
| March 31, 2021 | 13.80B |
| December 31, 2020 | 13.61B |
| September 30, 2020 | 13.72B |
| Date | Value |
|---|---|
| June 30, 2020 | 13.07B |
| March 31, 2020 | 11.53B |
| December 31, 2019 | 11.54B |
| September 30, 2019 | 11.27B |
| June 30, 2019 | 10.99B |
| March 31, 2019 | 10.88B |
| December 31, 2018 | 10.78B |
| September 30, 2018 | 10.46B |
| June 30, 2018 | 8.603B |
| March 31, 2018 | 8.69B |
| December 31, 2017 | 8.586B |
| September 30, 2017 | 9.288B |
| June 30, 2017 | 7.802B |
| March 31, 2017 | 7.649B |
| December 31, 2016 | 7.649B |
| September 30, 2016 | 7.715B |
| June 30, 2016 | 7.518B |
| March 31, 2016 | 7.453B |
| December 31, 2015 | 7.913B |
| September 30, 2015 | 6.686B |
| June 30, 2015 | 6.598B |
| March 31, 2015 | 6.43B |
| December 31, 2014 | 6.607B |
| September 30, 2014 | 6.527B |
| June 30, 2014 | 6.522B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Phibro Animal Health Corp. | 1.515B |
| Merck & Co., Inc. | 132.77B |
| Bristol Myers Squibb Co. | 88.77B |
| Amneal Pharmaceuticals, Inc. | 5.267B |
| Eli Lilly & Co. | 148.07B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.78B |
| Shareholders Equity (Quarterly) | 3.303B |
| Debt to Equity Ratio | 2.796 |
| Current Ratio | 2.346 |
| Net Debt Paydown Yield | -1.72% |